C @ logo
CEO

C @

Short interest
0.04%
as of 19 Oct 2011
Reported shorts
200K
Shares on issue
487.722M

C @ (CEO) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
1d ago

AdNeo Limited to Host FY26 Investor Webinar with CEO Angus Washington on October 20, 2026

AdNeo Limited (ASX:AD1) has scheduled an investor webinar hosted by Peak Asset Management on Tuesday, 20 October 2026 at 11:00am AEDT. CEO and Managing Director Angus Washington will present the company's FY26 financial results and growth strategy, followed by a live Q&A session. Key Highlights Investor webinar set for 20 October 2026 at 11:00am AEDT, hosted by Peak Asset Management FY26 operating revenue reached $9.6 million, marking a 97% increase over FY25 FY26 underlying EBITDA improv...

Kalkine
Neutral
1d ago

Carma Limited Announces 2026 AGM on 13 November with Six Key Resolutions Including CEO and CCO STI Rights

Carma Limited (ASX:CMA) has scheduled its 2026 Annual General Meeting for Friday, 13 November 2026 at 11.00am AEDT, to be held at 219-241 Cleveland Street, Strawberry Hills, NSW 2012. Shareholders will vote on six resolutions, notably including the proposed issuance of STI Restricted Rights to Chief Executive Officer Lachlan MacGregor and Chief Commercial Officer Yosuke Hall. Key Points The AGM is set as an in-person meeting on 13 November 2026 at 11.00am AEDT in Strawberry Hills, NSW Six res...

Kalkine
Neutral
6d ago

ResMed CEO Michael J. Farrell Executes Stock Option and Sells 4,991 Shares on October 7, 2026

On 7 October 2026, ResMed Inc (ASX:RMD) Chairman and CEO Michael J. Farrell exercised stock options and sold 4,991 shares of ResMed common stock, as detailed in a Form 4 filing submitted to the United States Securities and Exchange Commission. Key Highlights Michael J. Farrell exercised 4,991 ResMed stock options at an exercise price of $146.34 per share on 7 October 2026. He sold 4,991 shares simultaneously at a weighted average price of $226.3349, with individual trades ranging from $222.21...

Kalkine
Neutral
5 Oct

What comes next for Adairs as it begins a CEO search?

Highlights Adairs chief executive Elle Roseby has resigned and is expected to remain with the group until her notice period ends, while the board searches for a successor. A new executive general manager role for the Adairs brand and an expanded remit for the chief financial officer take effect as part of the transition. The annual general meeting in Melbourne is the next confirmed event, alongside further progress on Focus on Furniture, Mocka store openings and a new ERP system. Adairs Limit...

Kalkine
Neutral
14 Sept

Range International Appoints Richard Jenkins as Interim CEO After Russell Kennett Steps Down

Range International (ASX:RAN) announced on 14 September 2026 that Russell Kennett has resigned as Chief Executive Officer, with Executive Chairman Richard Jenkins stepping in as Interim CEO effective immediately, according to the company’s filing. Key Points Russell Kennett resigns as CEO immediately; Richard Jenkins named Interim CEO with no significant changes to his current remuneration. Richard Jenkins will dedicate a substantial portion of his time in Surabaya, Indonesia, overseeing Re...

Kalkine
Neutral
4 Sept

Krakatoa Resources Plans 90 Million Performance Rights Grant to Directors and CEO as Compensation

Krakatoa Resources Limited (ASX:KTA) has submitted a proposal to the ASX to issue up to 90,000,000 performance rights to its directors and CEO as part of their remuneration package, with a proposed issuance date of 6 October 2026. Key Highlights Krakatoa Resources intends to grant 90,000,000 performance rights to directors and the CEO as compensation. These performance rights vest when the 10-day volume weighted average price (VWAP) reaches $0.015 and have an exercise price of AUD $0.0000. Ea...

Kalkine
Neutral
31 Aug

Amcor CEO Peter Konieczny Reports Share Transactions in SEC Form 4 Filing on August 28, 2026

Amcor plc (ASX:AMC) announced that CEO Peter Konieczny submitted a Form 4 to the US Securities and Exchange Commission on 28 August 2026, detailing changes in his beneficial ownership of ordinary shares following the vesting of equity awards under the company’s long-term incentive programs. Key Points On 28 August 2026, CEO Peter Konieczny acquired 9,753.20 ordinary shares through the vesting of restricted stock units, increasing his directly held shares to 149,279.20. 517 shares were withh...

Kalkine
Neutral
14 Aug

JCurve Solutions Allocates 2 Million Shares Following CEO Service Rights Tranche 3 Vesting

On 14 August 2026, JCurve Solutions Limited (ASX:JCS) issued and allotted 2,000,000 fully paid ordinary shares after the vesting of Tranche 3 of the CEO Service Rights. The company also submitted a cleansing notice under Section 708A(5)(e) of the Corporations Act 2001. Key Highlights 2,000,000 fully paid ordinary shares issued on 14 August 2026 Shares issued due to vesting of CEO Service Rights Tranche 3 Initial performance rights allotments announced on 12 July 2023 and 14 December 2023 Shar...

Kalkine
Neutral
14 Aug

JCurve Solutions Issues 2 Million Shares After CEO Service Rights Conversion on August 14, 2026

JCurve Solutions Ltd (ASX:JCS) has applied for the listing of 2,000,000 fully paid ordinary shares on the ASX following the conversion of Tranche 3 CEO Service Rights held by key management personnel Christopher King, with the shares issued on 14 August 2026. Key Points 2,000,000 fully paid ordinary shares issued on 14 August 2026 after service rights conversion Shares converted from JCSAD Service Rights by KMP Christopher King at AUD $0.00 per security Conversion pertains to Tranche 3 CEO Se...

Kalkine
Neutral
11 Aug

Solvar Limited to Announce FY2026 Financial Results on 19 August with CEO and CFO Hosting Webinar

Solvar Limited (ASX:SVR) has announced it will publish its FY2026 full-year financial results on Wednesday, 19 August 2026, accompanied by a webinar at 11:00am AEST the same day to review the outcomes. Key Highlights FY2026 financial results scheduled for release on Wednesday, 19 August 2026 Webinar to be held at 11:00am AEST on 19 August 2026 coinciding with results announcement Presentation by Managing Director and CEO Scott Baldwin alongside CFO Siva Subramani Solvar is a leading specialis...

Kalkine
Neutral
5 Aug

NexGen Energy CEO Leigh Curyer Validates Interim Financial Statements for Q2 2026

Leigh Curyer, Chief Executive Officer of NexGen Energy Ltd. (ASX:NXG), has officially certified the company's interim financial report and Management Discussion and Analysis for the quarter ending June 30, 2026. The certification confirms that these filings are free from any false material statements and accurately reflect NexGen Energy's financial status, performance, and cash flow. Key Highlights CEO Leigh Curyer certified the interim financial documents dated August 4, 2026, for the period...

Kalkine
Neutral
3 Aug

Alkane Resources CEO Nic Earner to Speak at Diggers & Dealers Mining Forum on August 4, 2026

Alkane Resources Limited (ASX:ALK) announced that Managing Director and CEO Nic Earner will present at the upcoming Diggers & Dealers Mining Forum on Tuesday, 4 August 2026, at 10:45am Australian Western Standard Time. The company submitted the announcement on 3 August 2026, including the presentation slides intended for the forum. Key Highlights Nic Earner, Managing Director and CEO, is set to present at the Diggers & Dealers Mining Forum on 4 August 2026 at 10:45am AWST. The presentation wa...

Kalkine
Neutral
3 Aug

375,000 Options Vest for Koala Company CEO Dany Milham After Meeting Employment Condition

The Koala Company Limited (ASX:KOA) announced that 375,000 options held by its CEO and Executive Director, Dany Milham, have vested following the fulfillment of the relevant vesting condition, as per a company filing dated 3 August 2026. Key Points CEO and Executive Director Dany Milham’s 375,000 options vested on 3 August 2026. Vesting required continuous employment with the company until 1 July 2026. Options were granted in March 2025 with an exercise price of $3.30 each. Milham received ...

Kalkine
Neutral
29 July

Vectus Biosystems CEO Tara Speranza Converts 163,500 Share Options After Meeting Vesting Milestones

Vectus Biosystems Limited (ASX: VBS) has approved the issuance of 176,703 fully paid ordinary shares following the exercise of employee share options. CEO and CTO Tara Speranza exercised 163,500 options linked to share price performance targets. The company’s update on 29 July 2026 confirms all vesting conditions were met, increasing total quoted shares to 61,867,051. Key Points Vectus Biosystems Limited (VBS) is an ASX-listed biotech firm developing advanced biosystems solutions. CEO and C...

Kalkine
Neutral
27 July

SomnoMed Appoints Karen Borg as Sole CEO and Unveils Virtus Oral Appliance for Sleep Bruxism and OSA

SomnoMed Limited (ASX: SOM), a prominent provider of oral appliance therapies for obstructive sleep apnea (OSA) and related sleep breathing disorders, announced a leadership change with Karen Borg becoming the sole Chief Executive Officer after Amrita Blickstead stepped down as Co-CEO. Concurrently, the company disclosed preliminary FY26 financial results with revenues between $114 million and $115 million and launched Virtus globally—a specialized therapy designed to treat the estimated 50% o...

Kalkine
Neutral
24 July

RocketBoots CEO Joel Rappolt Receives Updated Employment Terms and 3 Million Performance Rights Amid International Expansion

RocketBoots Limited (ASX:ROC) has revealed key changes to its executive leadership, including an updated employment agreement for CEO Joel Rappolt effective from FY27, alongside the resignation of co-Company Secretary Cameron Petricevic. The company confirmed Rappolt's annual base salary at $375,000 gross and granted him 3 million performance rights divided into two tranches, with vesting contingent on continuous employment through September 2027. These adjustments follow a thorough market revie...

Kalkine
Neutral
24 July

Alfabs CEO Matthew Torrance Inadvertently Sells 1,340 Shares Outside Approved Trading Window, Company Confirms Policy Breach

Alfabs Australia Limited (ASX: AAL), a diversified mining and engineering firm based in Australia, has revealed an unintentional violation of its Securities Trading Policy by CEO Matthew Torrance on 20 July 2026. Torrance sold 1,340 ordinary shares outside the sanctioned trading periods due to a clerical mistake linked to settling an unrelated personal share purchase. The company confirmed Torrance had no access to any non-public, market-sensitive information at the time of the transaction. The ...

Kalkine
Neutral
21 July

Alterity Therapeutics CEO to Speak at Virtual BTIG Biotechnology Conference 2026 on July 28-29

Alterity Therapeutics Limited (ASX: ATH, NASDAQ: ATHE), a clinical-stage biotech firm focused on disease-modifying therapies for neurodegenerative disorders, announced that CEO Dr. David Stamler will present at the virtual BTIG Biotechnology Conference 2026 on 28–29 July 2026. During the event, the company will hold one-on-one investor meetings to discuss its lead candidate ATH434 and progress toward initiating a Phase 3 pivotal trial for Multiple System Atrophy (MSA). Key Highlights Alteri...

Kalkine
Neutral
20 July

Riedel Resources Grants 40 Million Performance Rights to Directors and Incoming CEO Paul Schmiede

On 20 July 2026, Riedel Resources Limited (ASX: RIE) issued 40 million unquoted performance rights as part of its employee incentive scheme, allocating 30 million to company directors and 10 million to the newly appointed Chief Executive Officer, Paul Schmiede. These performance rights carry transfer restrictions and will remain unlisted on the ASX until those restrictions are lifted. The issuance was approved by shareholders and executed under an exception to the standard ASX listing rules. K...